<VariationArchive VariationID="584339" VariationName="NC_000023.11:g.(?_123885637)_(123892793_?)del" VariationType="Deletion" Accession="VCV000584339" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2018-10-10" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="575283" VariationID="584339">
      <GeneList>
        <Gene Symbol="XIAP" FullName="X-linked inhibitor of apoptosis" GeneID="331" HGNC_ID="HGNC:592" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq25</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="123859708" stop="123913972" display_start="123859708" display_stop="123913972" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="122993661" stop="123047828" display_start="122993661" display_stop="123047828" Strand="+" />
          </Location>
          <OMIM>300079</OMIM>
          <Haploinsufficiency last_evaluated="2022-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=XIAP">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-07-27" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=XIAP">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NC_000023.11:g.(?_123885637)_(123892793_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq25</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" innerStart="123885637" innerStop="123892793" display_start="123885637" display_stop="123892793" variantLength="7157" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" innerStart="123019487" innerStop="123026643" display_start="123019487" display_stop="123026643" variantLength="7157" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.(?_123885637)_(123892793_?)del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.(?_123885637)_(123892793_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.(?_123019487)_(123026643_?)del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.(?_123019487)_(123026643_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000023.11:g.(?_123885637)_(123892793_?)del AND X-linked lymphoproliferative disease due to XIAP deficiency" Accession="RCV000708487" Version="6">
        <ClassifiedConditionList TraitSetID="3179">
          <ClassifiedCondition DB="MedGen" ID="C1845076">X-linked lymphoproliferative disease due to XIAP deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-06-02" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2018-06-02" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-10-10" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17080092</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21119115</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25666262</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3179" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2711" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">XIAP DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="300635" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lymphoproliferative syndrome 2, X-linked</ElementValue>
                <XRef ID="X-linked+lymphoproliferative+syndrome+2/9494" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">X-linked lymphoproliferative disease due to XIAP deficiency</ElementValue>
                <XRef ID="MONDO:0010385" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">XLP2</ElementValue>
                <XRef Type="MIM" ID="300635" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10916" />
                <XRef ID="10916" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">XIAP-Related Lymphoproliferative Disease, X-Linked</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">X-linked lymphoproliferative disease (XLP) has two recognizable subtypes, XLP1 and XLP2. XLP1 is characterized predominantly by one of three commonly recognized phenotypes: Inappropriate immune response to Epstein-Barr virus (EBV) infection leading to hemophagocytic lymphohistiocytosis (HLH) or severe mononucleosis. Dysgammaglobulinemia. Lymphoproliferative disease (malignant lymphoma). XLP2 is most often characterized by HLH (often associated with EBV), dysgammaglobulinemia, and inflammatory bowel disease. HLH resulting from EBV infection is associated with an unregulated and exaggerated immune response with widespread proliferation of cytotoxic T cells, EBV-infected B cells, and macrophages. Dysgammaglobulinemia is typically hypogammaglobulinemia of one or more immunoglobulin subclasses. The malignant lymphomas are typically B-cell lymphomas, non-Hodgkin type, often extranodal, and in particular involving the intestine.</Attribute>
                <XRef ID="NBK1406" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301580</ID>
                <ID Source="BookShelf">NBK1406</ID>
              </Citation>
              <XRef ID="2442" DB="Orphanet" />
              <XRef ID="538934" DB="Orphanet" />
              <XRef ID="C1845076" DB="MedGen" />
              <XRef ID="MONDO:0010385" DB="MONDO" />
              <XRef Type="MIM" ID="300635" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1609623" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2018-10-10">
        <ClinVarSubmissionID localKey="NM_001167.3_X_Deletion (exons 2-5)|MedGen:C1845076" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000837597" DateUpdated="2024-06-09" DateCreated="2018-10-10" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-06-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17080092</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21119115</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25666262</ID>
          </Citation>
          <Comment>Loss-of-function variants in XIAP are known to be pathogenic (PMID: 17080092, 21119115, 25666262). Deletions of exons 2-5 have not been reported in the literature in individuals with XIAP-related disease; however, smaller deletions encompassed within this larger event that include the initiator codon have been reported in individuals affected with X-linked lymphoproliferative syndrome (PMID:¬†27815752,¬†17080092). For these reasons, this variant has been classified as Pathogenic. This variant is a gross deletion of the genomic region encompassing exons 2-5 of the XIAP gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 5 of the XIAP gene. This is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="XIAP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000023.10:g.(?_123019487)_(123026643_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1845076" Type="CUI" />
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">28492532</ID>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB4474525</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1609623" TraitType="Disease" MappingType="XRef" MappingValue="C1845076" MappingRef="MedGen">
        <MedGen CUI="C1845076" Name="X-linked lymphoproliferative disease due to XIAP deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

